Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chamomile extract vs mefenamic acid for premenstrual syndrome
IRCT201201258801N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Mefenamic acid in premenstrual syndrome (PMS) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Change in premenstrual syndrome intensity. Started Dec 2011; status: completed.
02
Drugs
Mefenamic acid
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on IRCT201201258801N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201201258801N2.